Capital Group Investment Management PTE. LTD. Raises Stake in The Cooper Companies, Inc. $COO

Capital Group Investment Management PTE. LTD. raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 75.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 24,195 shares of the medical device company’s stock after purchasing an additional 10,399 shares during the quarter. Capital Group Investment Management PTE. LTD.’s holdings in Cooper Companies were worth $1,659,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in COO. Sustainable Growth Advisers LP acquired a new stake in shares of Cooper Companies during the second quarter worth about $240,881,000. Ameriprise Financial Inc. increased its position in Cooper Companies by 98.8% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock valued at $241,120,000 after acquiring an additional 1,683,561 shares during the period. Franklin Resources Inc. increased its position in Cooper Companies by 7,723.3% in the 2nd quarter. Franklin Resources Inc. now owns 1,569,512 shares of the medical device company’s stock valued at $111,686,000 after acquiring an additional 1,549,450 shares during the period. Massachusetts Financial Services Co. MA raised its stake in Cooper Companies by 96.9% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after acquiring an additional 1,525,693 shares during the last quarter. Finally, Findlay Park Partners LLP raised its stake in Cooper Companies by 312.5% during the 2nd quarter. Findlay Park Partners LLP now owns 1,815,900 shares of the medical device company’s stock valued at $129,219,000 after acquiring an additional 1,375,657 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Shares of COO stock opened at $75.82 on Tuesday. The company has a market cap of $14.79 billion, a price-to-earnings ratio of 37.53, a price-to-earnings-growth ratio of 2.13 and a beta of 1.02. The stock has a 50 day simple moving average of $81.98 and a 200-day simple moving average of $76.02. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $89.83. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the previous year, the business earned $0.92 earnings per share. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies News Summary

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Insiders bought stock in December and into early March, signaling management confidence and supporting a rebound thesis; the article argues buybacks and a healthy balance sheet underpin the long-term outlook. CooperCompanies Insiders Buy as Rebound Setup Forms
• Positive Sentiment: An analyst raised Cooper’s price target to $103, a bullish signal that highlights upside potential from current levels. Cooper Companies (NASDAQ:COO) Price Target Raised to $103.00
• Positive Sentiment: Coverage pieces (Zacks) reiterate Cooper as a long-term value/growth name, citing durable contact-lens and women’s-health franchises and mid-single-digit revenue growth with earnings leverage. Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term
• Neutral Sentiment: A Zacks piece highlights the importance of monitoring international revenue trends — useful for modeling but not an immediate catalyst. Investing in The Cooper Companies (COO)? Don’t Miss Assessing Its International Revenue Trends
• Negative Sentiment: Citigroup cut its price target to $87, adding downward pressure and reflecting analyst caution — this helps explain some of today’s weakness. Citigroup Cuts Cooper Companies (NASDAQ:COO) Price Target to $87.00

Insider Buying and Selling

In related news, Director Cynthia L. Lucchese purchased 1,784 shares of the business’s stock in a transaction dated Monday, December 22nd. The stock was acquired at an average price of $84.06 per share, for a total transaction of $149,963.04. Following the acquisition, the director directly owned 9,445 shares of the company’s stock, valued at $793,946.70. This trade represents a 23.29% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Holly R. Sheffield acquired 1,230 shares of Cooper Companies stock in a transaction that occurred on Tuesday, December 16th. The stock was bought at an average price of $80.75 per share, with a total value of $99,322.50. Following the purchase, the insider directly owned 39,052 shares of the company’s stock, valued at approximately $3,153,449. This trade represents a 3.25% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 16,014 shares of company stock valued at $1,304,416 in the last quarter. Corporate insiders own 2.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on COO. Citigroup lowered their target price on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Friday. Mizuho set a $100.00 price target on Cooper Companies and gave the stock an “outperform” rating in a report on Friday, December 5th. JPMorgan Chase & Co. lifted their price objective on shares of Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research report on Friday, December 5th. Wells Fargo & Company boosted their price objective on shares of Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a research note on Friday, December 5th. Finally, Barclays upped their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus price target of $90.79.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.